neratinib (HKI-272)

neratinib · Puma Biotechnology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for neratinib (HKI-272), covering 2018-12-19 to 2018-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor [Phase 1]